Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy

RecruitingOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

July 1, 2028

Study Completion Date

December 31, 2028

Conditions
Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
Interventions
OTHER

Observational

This is a prospective observational study with observation only and no intervention

Trial Locations (1)

200123

RECRUITING

Shanghai Renji Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Tianjin Medical University Second Hospital

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

West China Hospital

OTHER

collaborator

Ruijin Hospital

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

collaborator

The First Affiliated Hospital of University of Science and Technology of China

OTHER

collaborator

The Second Hospital of Anhui Medical University

OTHER

collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

lead

RenJi Hospital

OTHER